Stock MBRX MOLECULIN BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Moleculin Biotech, Inc.

Equities

MBRX

US60855D3098

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
4.95 USD -2.56% Intraday chart for Moleculin Biotech, Inc. +6.00% -61.56%
May. 15 Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (Nu 21C06) CI
May. 13 Transcript : Moleculin Biotech, Inc., Q1 2024 Earnings Call, May 13, 2024
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
MOLECULIN BIOTECH, INC.
Bio Therapeutic Drugs
-2.56%+6.00%-61.56%-46.77%-95.13% 11.32M
Neutral
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. MBRX Stock
  4. Charts Moleculin Biotech, Inc.
  5. Comparison Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW